The Food and Drug Administration (FDA) has recently issued warning letters to companies that produce CBD and Delta-8 THC edibles due to inadequate labeling and misleading information to consumers. The FDA is urging these companies to make sure their products are properly labeled and tested before being sold. With the growing market of marijuana-derived products in the form of lotions, tinctures, and foods, the FDA has called on Congress to create new rules for CBD products due to too many unknowns about the product and its safety.
What Are The Labelling Requirements for CBD and Delta-8 THC Products?
To ensure consumer safety, the FDA has specified labeling requirements for CBD and Delta-8 THC products, including:
Specifying the amount of CBD or Delta-8 THC in each serving
Validated through third-party testing laboratories
Other active ingredients
Products that do not meet these standards may be subject to recall or disposal. Consumers are encouraged to check the labels of CBD and Delta-8 THC products before purchasing to make sure they are getting what they expect.
Unknown Safety of CBD Products
The FDA has oversight of CBD because it is the active ingredient in an approved prescription drug, Epidiolex, used to treat two rare seizure disorders. However, there is not enough evidence to confirm the safety of CBD when used in foods or as a dietary supplement. The FDA has also expressed concerns about the effects of CBD on the liver, the male reproductive system, and pregnant women and children.
What Are The Potential New Rules for CBD Products?
The FDA has called on Congress to create new rules for CBD products, which could include:
Clear labels
Regulations regarding contaminants
Limits on CBD levels
Minimum purchase age
Regulations for CBD products for animals
The FDA’s action has come after repeated calls from lawmakers, advocates, and consumer groups for CBD to be allowed in foods and supplements. The FDA has denied three petitions from advocacy groups that asked the agency to allow products containing hemp to be marketed as dietary supplements.
Consumer Safety as the Top Priority
The FDA will continue to take action against CBD and other cannabis products to protect the public. The agency has sent warning letters to some companies making health claims for CBD. FDA appears to be concerned with ensuring consumer safety by making sure CBD products are properly labeled, third-party tested, and free of contaminants and heavy metals. Congress is being referred to explore potential regulatory pathways by the regulatory organization.
Conclusion
With the growing demand for CBD products, more regulation is needed to keep fly-by-night marketers from profiting off the demand for CBD without proper labeling or third-party testing.
The FDA has called on Congress to create new rules for CBD products to ensure consumer safety. The FDA is looking to make sure that CBD products are properly labeled, third-party tested, and free of contaminants and heavy metals.
How CBD Brand Reviews Can Assist Consumers
CBD Brand Review enables consumers to eliminate the uncertainty associated with purchasing CBD products. With their comprehensive evaluation process, CBD Brand Review saves consumers the timely and frustrating process of evaluating some 3500 CBD brands, allowing them to quickly identify those companies doing their best in bringing high-quality, third-party tested products to this massive CBD market.
CBD Brand Review understands the importance of proper labeling and third-party testing and supports brands that are already doing so, well ahead of any FDA or Congress mandate. Customers can be confident that they are purchasing the best and safest CBD products available by utilizing the services of CBD Brand Review.
